Search research articles
Contact Us
Filters
Showing results (31-40 of 42) with videos related to
Page
of 5
Sort By:
Antimicrobial Agents and Chemotherapy
|
March 7, 2018
Exploring the Pharmacokinetic/Pharmacodynamic Relationship of Relebactam (MK-7655) in Combination with Imipenem in a Hollow-Fiber Infection Model
Jin Wu, Fred Racine, Michael K Wismer, et al.
Journal of Natural Products
|
June 24, 2008
Isolation, structure, and antibacterial activity of phaeosphenone from a Phaeosphaeria sp. discovered by antisense strategy
Chaowei Zhang, John G Ondeyka, Deborah L Zink, et al.
Open Forum Infectious Diseases
|
November 26, 2020
In Vitro Hollow-Fiber Studies Assessing Antibacterial Activity of Ceftolozane/Tazobactam Against Multidrug-Resistant <i>Pseudomonas Aeruginosa</i>
Donna Carr, Zufei Zhang, Qian Si, et al.
International Journal of Antimicrobial Agents
|
October 22, 2023
Antimicrobial surveillance: A 20-year history of the SMART approach to addressing global antimicrobial resistance into the future
Rafael Cantón, Thomas Gottlieb, Geoffrey W Coombs, et al.
Journal of the American Chemical Society
|
August 14, 2008
Isolation, structure, and antibacterial activity of philipimycin, a thiazolyl peptide discovered from Actinoplanes philippinensis MA7347
Chaowei Zhang, James Occi, Prakash Masurekar, et al.
The Journal of Antimicrobial Chemotherapy
|
January 13, 2022
Clinical and microbiological outcomes, by causative pathogen, in the ASPECT-NP randomized, controlled, Phase 3 trial comparing ceftolozane/tazobactam and meropenem for treatment of hospital-acquired/ventilator-associated bacterial pneumonia
Ignacio Martin-Loeches, Jean-François Timsit, Marin H Kollef, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 26, 2007
Discovery of platencin, a dual FabF and FabH inhibitor with in vivo antibiotic properties
Jun Wang, Srinivas Kodali, Sang Ho Lee, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 7, 2015
Novel orally active inhibitors of β-1,3-glucan synthesis derived from enfumafungin
James M Apgar, Robert R Wilkening, Mark L Greenlee, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 7, 2020
Ibrexafungerp: An orally active β-1,3-glucan synthesis inhibitor
James M Apgar, Robert R Wilkening, Dann L Parker, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 3, 2020
MK-5204: An orally active β-1,3-glucan synthesis inhibitor
James M Apgar, Robert R Wilkening, Dann L Parker, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 42) with videos related to
Sort By:
Page
of 5
Antimicrobial Agents and Chemotherapy
|
March 7, 2018
Exploring the Pharmacokinetic/Pharmacodynamic Relationship of Relebactam (MK-7655) in Combination with Imipenem in a Hollow-Fiber Infection Model
Jin Wu, Fred Racine, Michael K Wismer, et al.
Journal of Natural Products
|
June 24, 2008
Isolation, structure, and antibacterial activity of phaeosphenone from a Phaeosphaeria sp. discovered by antisense strategy
Chaowei Zhang, John G Ondeyka, Deborah L Zink, et al.
Open Forum Infectious Diseases
|
November 26, 2020
In Vitro Hollow-Fiber Studies Assessing Antibacterial Activity of Ceftolozane/Tazobactam Against Multidrug-Resistant <i>Pseudomonas Aeruginosa</i>
Donna Carr, Zufei Zhang, Qian Si, et al.
International Journal of Antimicrobial Agents
|
October 22, 2023
Antimicrobial surveillance: A 20-year history of the SMART approach to addressing global antimicrobial resistance into the future
Rafael Cantón, Thomas Gottlieb, Geoffrey W Coombs, et al.
Journal of the American Chemical Society
|
August 14, 2008
Isolation, structure, and antibacterial activity of philipimycin, a thiazolyl peptide discovered from Actinoplanes philippinensis MA7347
Chaowei Zhang, James Occi, Prakash Masurekar, et al.
The Journal of Antimicrobial Chemotherapy
|
January 13, 2022
Clinical and microbiological outcomes, by causative pathogen, in the ASPECT-NP randomized, controlled, Phase 3 trial comparing ceftolozane/tazobactam and meropenem for treatment of hospital-acquired/ventilator-associated bacterial pneumonia
Ignacio Martin-Loeches, Jean-François Timsit, Marin H Kollef, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 26, 2007
Discovery of platencin, a dual FabF and FabH inhibitor with in vivo antibiotic properties
Jun Wang, Srinivas Kodali, Sang Ho Lee, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 7, 2015
Novel orally active inhibitors of β-1,3-glucan synthesis derived from enfumafungin
James M Apgar, Robert R Wilkening, Mark L Greenlee, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 7, 2020
Ibrexafungerp: An orally active β-1,3-glucan synthesis inhibitor
James M Apgar, Robert R Wilkening, Dann L Parker, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 3, 2020
MK-5204: An orally active β-1,3-glucan synthesis inhibitor
James M Apgar, Robert R Wilkening, Dann L Parker, et al.
Page
of 5